In a significant move within the energy sector, Shell and Saudi Aramco have entered advanced price negotiations to acquire the assets of Pavilion Energy, an LNG (liquefied natural gas) trading company owned by Temasek. According to three sources familiar with the matter, this development follows after both companies completed the due diligence process.
The Race for a Strategic Asset
Pavilion Energy, established a decade ago by Singapore's state investment firm Temasek, has grown to become a key player in the LNG market. With the assets potentially valued at over US$2 billion, this deal marks a critical juncture for the involved parties. According to insiders, neither Pavilion Energy, Temasek, Shell, nor Barclays, advising Temasek, have made official comments regarding the ongoing negotiations.
Similarly, Saudi Aramco's gas unit, which is leading the charge, has remained silent on inquiries about the deal.
Strategic Implications for Aramco and Shell
For Saudi Aramco, known primarily for its oil production, acquiring Pavilion's assets would significantly bolster its position in the global LNG market. The company is ramping up its gas exploration activities and aims to increase its gas production by over 60% from 2021 levels by 2030.
According to Business Times, this ambition is part of a broader strategy that includes investing in LNG projects worldwide—demonstrated last year through a US$500 million investment in MidOcean Energy.
On the other hand, Shell has a substantial presence in the global LNG market, with LNG trading accounting for nearly a third of its profit in the last quarter of the previous year. The company views gas and LNG as pivotal elements of the global energy transition, helping phase out coal in power generation for a cleaner, less polluting alternative.
Gulf Business noted that the acquisition of Pavilion Energy by either Shell or Saudi Aramco would reshape the LNG trading landscape and highlight the growing emphasis on cleaner energy sources in the global push for environmental sustainability.
Photo: Jethro Carullo/Unsplash


Weight-Loss Drug Ads Take Over the Super Bowl as Pharma Embraces Direct-to-Consumer Marketing
SpaceX Pushes for Early Stock Index Inclusion Ahead of Potential Record-Breaking IPO
OpenAI Expands Enterprise AI Strategy With Major Hiring Push Ahead of New Business Offering
FDA Targets Hims & Hers Over $49 Weight-Loss Pill, Raising Legal and Safety Concerns
Washington Post Publisher Will Lewis Steps Down After Layoffs
Global PC Makers Eye Chinese Memory Chip Suppliers Amid Ongoing Supply Crunch
Ford and Geely Explore Strategic Manufacturing Partnership in Europe
Alphabet’s Massive AI Spending Surge Signals Confidence in Google’s Growth Engine
TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans
Missouri Judge Dismisses Lawsuit Challenging Starbucks’ Diversity and Inclusion Policies
American Airlines CEO to Meet Pilots Union Amid Storm Response and Financial Concerns
Once Upon a Farm Raises Nearly $198 Million in IPO, Valued at Over $724 Million
Trump Backs Nexstar–Tegna Merger Amid Shifting U.S. Media Landscape
Rio Tinto Shares Hit Record High After Ending Glencore Merger Talks
SoftBank Shares Slide After Arm Earnings Miss Fuels Tech Stock Sell-Off
Uber Ordered to Pay $8.5 Million in Bellwether Sexual Assault Lawsuit
Prudential Financial Reports Higher Q4 Profit on Strong Underwriting and Investment Gains 



